The Archive · 3 posts
Revolutionising medicine! 🍀 Hemogenyx Pharmaceuticals (HEMO) pioneers cell therapies on LSE. Promising cures for deadly diseases! 💉
Hemogenyx has converted its Cellin letter of intent into a binding agreement covering HG-CT-1 manufacturing and delivery in Estonia.
August 11, 2026
Showing 2 of 3 posts
Hemogenyx Pharmaceuticals 2025 final results: Phase 1 HG-CT-1 trial progresses with DSMB clearance, but losses and dilution continue. Full analysis.
JoshuaMay 1, 2026
Hemogenyx Pharma achieves CAR-T Phase I milestone, doses first patient. Secures £5.2M funding for AML therapy development.
JoshuaApril 28, 2025